Vice President, Pharmaceutical Sciences jobs in United States
cer-icon
Apply on Employer Site
company-logo

Tango Therapeutics · 1 day ago

Vice President, Pharmaceutical Sciences

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets for cancer treatment. The VP of Pharmaceutical Sciences will be responsible for overseeing drug metabolism, pharmacokinetics, preclinical safety, and clinical pharmacology, while collaborating with teams to ensure successful IND and NDA submissions.

BiotechnologyHealth CareMedicalTherapeutics

Responsibilities

You will be a recognized expert in clinical pharmacology with a track record of success in research and development
Lead overall scientific, technical, and operational aspects of Pharmaceutical Science for R&D
Recruit, develop and mentor talent as you build Pharmaceutical Sciences
Collaborate with preclinical and clinical development teams to optimize study design and execution
Represent Pharmaceutical Science as subject matter expert on R&D teams and governance boards
Establish and maintain productive relationships with key internal business partners, consultants, and CROs

Qualification

Clinical pharmacologyDrug metabolismPharmacokineticsSmall molecule drug developmentHealth authority interactionsModelingSimulationMentoring talentGLPGCPICHTeam collaboration

Required

PhD or PharmD in clinical pharmacology, pharmacometrics, or related discipline with at least 15 years' experience in the pharmaceutical and/or biotech industry
Experience with small molecule drug development in oncology
In-depth knowledge of drug metabolism, pharmacokinetics, biopharmaceutics, drug-drug interactions, and translational science
Experience with health authority interactions
Experience as lead or contributing clinical pharmacologist on a successful NDA submission
Familiar with GLP, GCP, and ICH requirements
Practical experience in modeling and simulation
Highly motivated to work and collaborate in a fast-paced, high performing team

Company

Tango Therapeutics

twittertwittertwitter
company-logo
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

Funding

Current Stage
Public Company
Total Funding
$548M
Key Investors
Nextech InvestBoxer CapitalCasdin Capital
2025-10-23Post Ipo Equity· $197M
2021-08-11Post Ipo Equity· $186M
2021-08-11IPO

Leadership Team

leader-logo
Barbara Weber
President and CEO
linkedin
leader-logo
Jannik N. Andersen
Chief Scientific Officer
linkedin
Company data provided by crunchbase